Intrexon Corporation News Headlines

XON 
$28.02
*  
0.39
1.41%
Get XON Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading XON now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (12/12/14)
12/14/2014 6:42:00 AM - Seeking Alpha


Intrexon Moves Up In Market Cap Rank, Passing Denbury Resources
12/8/2014 4:39:57 PM - BNK Invest


Can Biotech Save Natural Gas Producers Billions in Flaring Costs?
11/29/2014 4:00:03 PM - Motley Fool


Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update
11/24/2014 2:26:00 AM - Seeking Alpha


Can the Rally in Intrexon (XON) Shares Continue? - Tale of the Tape
11/19/2014 8:46:15 AM - Zacks.com


US IPO Weekly Recap: Virgin America flies high as IPO market reaches 250 with 9 new offerings
11/14/2014 7:43:42 PM - Renaissance Capital


An unmet need for knees: Biotech Histogenics sets terms for $60 million IPO
11/14/2014 3:55:27 PM - Renaissance Capital


Earnings After The Bell - Nov 13
11/14/2014 5:07:00 AM - RTT News


Will Higher Expenses Hurt Intrexon (XON) Earnings in Q3? - Analyst Blog
11/12/2014 10:50:00 AM - Zacks.com


Intrexon (XON) Looks Good: Stock Moves 11% Higher - Tale of the Tape
11/12/2014 9:46:00 AM - Zacks.com


Commit To Purchase Intrexon Corp At $15, Earn 14.7% Using Options
10/27/2014 10:34:45 AM - BNK Invest


Monopoly Hunt - Why Competition Is For Losers
10/10/2014 9:22:00 PM - Seeking Alpha


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


Intrexon Corp. (XON) Is Accelerating To The Upside
10/7/2014 9:56:00 AM - RTT News


Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog
9/16/2014 4:00:00 PM - Zacks.com


The Antibiotic Resistance Triple Threat
9/4/2014 2:05:00 PM - Seeking Alpha


Greenlight Capital's Ideas That Are Most And Least Likely To Outperform
8/29/2014 3:02:00 PM - Seeking Alpha


Moving Average Crossover Alert: Intrexon (XON) - Tale of the Tape
8/27/2014 8:52:10 AM - Zacks.com


Oragenics: Interview With CEO Bonfiglio
8/24/2014 1:50:00 AM - Seeking Alpha


Tracking Dan Loeb's Third Point Portfolio - Q2 2014 Update
8/22/2014 4:44:00 AM - Seeking Alpha


Tracking David Einhorn's Portfolio - Q2 2014 Update
8/17/2014 9:17:00 AM - Seeking Alpha


After-Hours Earnings Report for August 14, 2014 : AMAT, A, JWN, ADSK, SINA, JCP, XON, AGRO, ULTR, EXTR, CACB, SVA
8/14/2014 1:00:02 PM - NASDAQ.com News


Ziopharm: Pipeline Expansion And Data Updates To Drive Near-Term Upside
7/29/2014 6:21:00 PM - Seeking Alpha


Ziopharm Joins The CAR Crowd
7/29/2014 9:04:00 AM - Seeking Alpha


The Sirens Of Ziopharm
6/15/2014 2:16:00 PM - Seeking Alpha